期刊文献+

Effect of valsartan on Lectin-like oxidized-low density lipoprotein receptor-1 expression in balloon-injured rat aorta

Effect of valsartan on Lectin-like oxidized-low density lipoprotein receptor-1 expression in balloon-injured rat aorta
原文传递
导出
摘要 Background It's established that Lectin-like involved in intimal hyperplasia after balloon injury oxidized low-density lipoprotein receptor-l(LOX-1) is The recent evidence also suggests that valsartan has an antiatheroscletic effect. In this study, the expression of LOX-1 and the effect of valsartan on its expression was investigated in rat aorta after balloon injury. Methods Rat model of aortic endothelial denudation was induced by 2F balloon catheter. Rats were randomly divided into three groups: control, operationand valsartan treatment. The aortic tissues were taken from rats in each group on days 14 and 28 after surgery. The thickness of vascular wall was measured with HE stain, LOX-1 mRNA and protein were determined by reverse transcription-polymerse chain reaction (RT-PCR) and immunohistochemistry, respectively. Results Compared with the control group, significant intimal thickening was observed at day 14 and 28 after injury. Compared with the operation group, intimal thickness of each time point was significantly decreased in valsartan treatment group. At day 14 and 28 after balloon injury, the expression levels of LOX-1 mRNA and protein were significantly increased, and were greatly decreased after valsartan treatment. Conclusions The expression of LOX-1 is increased after endothelial injury. Valsartan inhibits aortic intimal thickening induced by endothelial denudation, which is associated with the downregulation of LOX-1 expression. Background It's established that Lectin-like involved in intimal hyperplasia after balloon injury oxidized low-density lipoprotein receptor-l(LOX-1) is The recent evidence also suggests that valsartan has an antiatheroscletic effect. In this study, the expression of LOX-1 and the effect of valsartan on its expression was investigated in rat aorta after balloon injury. Methods Rat model of aortic endothelial denudation was induced by 2F balloon catheter. Rats were randomly divided into three groups: control, operationand valsartan treatment. The aortic tissues were taken from rats in each group on days 14 and 28 after surgery. The thickness of vascular wall was measured with HE stain, LOX-1 mRNA and protein were determined by reverse transcription-polymerse chain reaction (RT-PCR) and immunohistochemistry, respectively. Results Compared with the control group, significant intimal thickening was observed at day 14 and 28 after injury. Compared with the operation group, intimal thickness of each time point was significantly decreased in valsartan treatment group. At day 14 and 28 after balloon injury, the expression levels of LOX-1 mRNA and protein were significantly increased, and were greatly decreased after valsartan treatment. Conclusions The expression of LOX-1 is increased after endothelial injury. Valsartan inhibits aortic intimal thickening induced by endothelial denudation, which is associated with the downregulation of LOX-1 expression.
出处 《South China Journal of Cardiology》 CAS 2015年第1期44-50,共7页 岭南心血管病杂志(英文版)
基金 supported by Science and Technology sponsor project of Shandong Province(No.2012G0021851)
关键词 vascular endothelial injury VALSARTAN LOX-1 vascular endothelial injury valsartan LOX-1
  • 相关文献

参考文献1

二级参考文献12

  • 1Curcio A TD,Indolfi C. Mechanisms of smooth muscle cell p oliferation and endothelial regeneration after vascular injury and stenting[J].Circulation,2011.1287–1296.
  • 2Rabelo LA,Alenina N,Bader M. ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease[J].Hypertension Research,2011.154–160.
  • 3Preusch MR,Vanakaris A,Bea F. Rosuvastatin reduces neointima formation in a rat model of balloon injury[J].European Journal of medical Research,2010.461–467.
  • 4Briones AM,Rodríguez-Criado N,Hernanz R. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress[J].Hypertension,2009.142–149.
  • 5Marx SO,Totary-Jain H,Marks AR. Vascular smooth muscle cell proliferation in restenosis[J].Circ Cardiovasc Interv,2011.104–111.
  • 6Santos RA,Ferreira AJ,Verano-Braga T. Angiotensin-converting enzyme 2,angiotensin-(1-7) and Mas:new players of the renin-angiotensin system[J].Journal of Endocrinology,2013.R1–R17.
  • 7Shi L,Mao C,Xu Z. Angiotensin-converting enzymes and drug discovery in cardiovascular diseases[J].Drug Discovery Today,2010.332–341.
  • 8Zhang F,Hu Y,Xu Q. Different effects of angiotensin II and angiotensin-(1-7)on vascular smooth muscle cell proliferation and migration[J].PLoS One,2010.e12323.
  • 9Xu W,Guo T,Zhang Y. The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1α expression[J].Experimental Cell Research,2011.1083–1892.
  • 10Wu JR,Liou SF,Lin SW. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling[J].Pharmacological Research,2009.48–56.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部